A new look for a new era in genomic technologies

About AGTA

Conference News

Molecular Microbiology Meeting (MMM2018), Sydney

11-12th April 2018

Waterview at Bicentennial Park, Sydney Olympic Park, NSW

Topics covered include: Emerging diagnostics, Bacteriophages, Synthetic biology, High-resolution imaging, Metagenomics and pathogen discovery, Real-time public health genomics, Antibiotic resistance, The microbiome. MMM2018 will have amazing speakers including local heroes; Vanessa Hayes, Torsten Seemann, Ian Paulsen and many more. Come and meet industry people (Illumina, Cepheid, Abbott Molecular, SpeeDx, AusDiagnostics, Roche, Hologic, Genetic Signatures), research scientists and clinicians. For more information, please go to the conference website hereRegister now!

Co-chairing opportunities

Available to ECR’s who have registered to attend MMM2018. If you’re interested in co-chairing a session please send an email to critical.infection@sydney.edu.au

 

AGBT Conference (Florida, USA) travel award recipient announced

Nicole_Cloonan_NewHeadshot1small

AGTA is pleased to announce that the winner of the inaugural ‘AGBT Travel Award’ is Assoc. Prof. Nicole Cloonan of the Faculty of Science (Biological sciences), University of Auckland.  Congratulations Nicole!

Nicole will be attending the Advances in Genome BioTechnology (general meeting) in Orlando Florida, USA from 12th-15th February 2018. This meeting provides a forum for exchanging information about the latest advances in sequencing technologies, experimental and analytical approaches for genomic studies, and their applications. It is attended by over 800 people including representatives from around 70 Universities and 280 companies.

We look forward to hearing Nicole when she delivers live Twitter feeds from the AGBT conference and written articles on conference highlights on her return. Good luck Nicole!

ABOUT AGTA

This is the homepage of the Australasian Genomic Technologies Association (AGTA)-previously AMATA. We are a not-for-profit association dedicated to advancing and promoting the field of genomics and genomic technologies in Australasia.

AGTA is the principal body for the promotion of genomics research in Australasia. We draw on the astounding breadth of genomics research and technology development across Australasia.

AGTA’s main purpose is to:

  • Foster communication & collaborations between Australasian research groups utilising genomic technologies
  • Convene and underwrite an annual meeting of members and facilitate workshops on the use of genomic technologies and the analysis of genomic data
  • Facilitate and accelerate genomic and related technology development in Australasia
  • Support student and early career researchers, the genomic technology leaders of the future

By joining AGTA, you can benefit from the collective depth and breadth of expertise of the AGTA community. For a full list of members benefits and to know why you should be a member of AGTA, please click here.

Please enjoy our new look - for a new era in genomic technologies.

RCPA Document – Standards for Clinical Databases of Genetic Variants

AGTA is committed to keeping abreast of changes in the genomic technologies landscape, including important applications such as clinical sequencing of genetic variants. The Human Genome Society of Australia (HGSA) has requested distribution of the following document regarding “Standards for Clinical Databases of Genetic Variants”. To read the document (v.1.0, released Dec. 2014) please click here.

 

News Feed

NEWS -

AGTA generally offers travel awards at each annual conference to assist participants from the more remote locations (relative to conference location) to attend. Travel Awards $900 awards to: Sandra...Keep Reading

NEWS -

2017 CONFERENCE AWARDS (Hobart) AGTA is pleased to announce the recipients of the 2017 Conference Awards. Congratulations to all recipients! Early Career Researcher Prizes Nigel Swanston Oral Award (...Keep Reading

View Full News Feed

Click to subscribe to future content.
Best used with IE/Edge or Safari.